Disruption of promoter methylation, chromatin modifications and structural changes mediated by CTCF can lead to the dysregulation of cancer-associated genes, including RARRES1 [24], HOXA10 [25], TERT [26] and PTGS2 [27]. This evidence concerns the gene CTCF and cancer.